Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
Bove R, Langdon D, Maciejowski M, Jasińska E, Dufek M, Abeyewickreme A, Rauh A, Fu H, Khan I A, Böhringer M, et al.
J Neurol. 2026 Jun 29; 273(7). PMID: 42371147.Abstract
